Page last updated: 2024-10-19

inositol and Spinocerebellar Ataxias

inositol has been researched along with Spinocerebellar Ataxias in 4 studies

Inositol: An isomer of glucose that has traditionally been considered to be a B vitamin although it has an uncertain status as a vitamin and a deficiency syndrome has not been identified in man. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1379) Inositol phospholipids are important in signal transduction.
inositol : Any cyclohexane-1,2,3,4,5,6-hexol.
1D-chiro-inositol : Belonging to the inositol family of compounds, D-chiro-inositol (DCI) is an isomer of glucose. It is an important secondary messenger in insulin signal transduction.
muco-inositol : An inositol that is cyclohexane-1,2,3,4,5,6-hexol having a (1R,2R,3r,4R,5S,6r)-configuration.

Spinocerebellar Ataxias: A group of predominately late-onset, cerebellar ataxias which have been divided into multiple subtypes based on clinical features and genetic mapping. Progressive ataxia is a central feature of these conditions, and in certain subtypes POLYNEUROPATHY; DYSARTHRIA; visual loss; and other disorders may develop. (From Joynt, Clinical Neurology, 1997, Ch65, pp 12-17; J Neuropathol Exp Neurol 1998 Jun;57(6):531-43)

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Cappuccio, G1
Apuzzo, D1
Passalacqua, P1
Parrini, E1
D'Amico, A1
Montini, T1
Brunetti-Pierri, N1
Joers, JM1
Deelchand, DK1
Lyu, T1
Emir, UE1
Hutter, D2
Gomez, CM2
Bushara, KO2
Eberly, LE3
Öz, G3
Kittelson, E1
Demirgöz, D1
Rainwater, O1
Orr, HT1
Clark, HB2
Tkác, I1
Gross, MD1
Jiang, H1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Clinical Trial Readiness for SCA1 and SCA3[NCT03487367]200 participants (Anticipated)Observational2018-08-16Active, not recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Other Studies

4 other studies available for inositol and Spinocerebellar Ataxias

ArticleYear
Long-term follow-up of an individual with ITPR1-related disorder.
    American journal of medical genetics. Part A, 2020, Volume: 182, Issue:7

    Topics: Cerebellum; Child; Developmental Disabilities; Follow-Up Studies; Humans; Inositol; Inositol 1,4,5-T

2020
Neurochemical abnormalities in premanifest and early spinocerebellar ataxias.
    Annals of neurology, 2018, Volume: 83, Issue:4

    Topics: Activities of Daily Living; Adult; Aged; Aspartic Acid; Ataxins; Brain; Brain Diseases, Metabolic; C

2018
Assessing recovery from neurodegeneration in spinocerebellar ataxia 1: Comparison of in vivo magnetic resonance spectroscopy with motor testing, gene expression and histology.
    Neurobiology of disease, 2015, Volume: 74

    Topics: Animals; Area Under Curve; Aspartic Acid; Ataxin-1; Cerebellum; Doxycycline; Gene Expression; Humans

2015
Neurochemical alterations in spinocerebellar ataxia type 1 and their correlations with clinical status.
    Movement disorders : official journal of the Movement Disorder Society, 2010, Jul-15, Volume: 25, Issue:9

    Topics: Analysis of Variance; Aspartic Acid; Brain Chemistry; Case-Control Studies; Female; Functional Later

2010